Vimeo
LinkedIn
Instagram
Share |

medtech

September 14, 2021

The chairman of Supernova Invest, the pioneer and leader of deep tech investment in France, will discuss how investors, families and companies can achieve their goals at the in-person MedTech Investing Europe Forum.

The chairman of Supernova Invest, the pioneer and leader of deep tech investment in France, will discuss how investors, families and companies can achieve their goals at the in-person MedTech Investing Europe Forum.

August 16, 2021

For an innovative investment to pay off, the pieces of the research and development puzzle need to fall into place perfectly—especially in life sciences and MedTech.

For an innovative investment to pay off, the pieces of the research and development puzzle need to fall into place perfectly—especially in life sciences and MedTech.

In Flanders, the northern region of Belgium, you’ll find all the required ingredients: companies that adapt quickly and work together, academic institutions and research centres that support the ambitions of entrepreneurs, government agencies that think with and support the world of business in a hands-on way. It’s all available in a compact and dense knowledge network.

July 27, 2021

Say Flanders, think research and technology. Belgium’s northern region is a well-known beacon of innovation. Its companies, research centres and knowledge institutions are at the basis of ground-breaking solutions in niches like digital, health and climate tech.

Say Flanders, think research and technology. Belgium’s northern region is a well-known beacon of innovation. Its companies, research centres and knowledge institutions are at the basis of ground-breaking solutions in niches like digital, health and climate tech.

Through its worldwide Science and Technology Offices, Flanders Investment and Trade helps Flanders build bridges of knowhow and innovative strength across the globe—and you can reap the rewards, too.

July 14, 2021

The medical technology industry is enjoying record levels of M&A activity. Deloitte’s 2020 MedTech review identified a 24% increase in transactions in Western Europe, with strong focus on diagnostics, orthopaedics and data driven innovation.

The medical technology industry is enjoying record levels of M&A activity. Deloitte’s 2020 MedTech review identified a 24% increase in transactions in Western Europe, with strong focus on diagnostics, orthopaedics and data driven innovation.

For many investors the strong growth prospects, resilient valuations and defensive nature of healthcare investments make this a very attractive market. Evaluate MedTech calculates $6 billion of venture financing was invested in 2019 and 2020, slightly down from the 2017 high of $7.8 billion.

June 25, 2021

As if healthcare systems around the world were not under huge pressure already, the Coronavirus pandemic has stretched healthcare systems to, and in cases, beyond their limit. Many systems have been forced to cancel routine operations and postpone in person appointments and diagnostic tests.

As if healthcare systems around the world were not under huge pressure already, the Coronavirus pandemic has stretched healthcare systems to, and in cases, beyond their limit. Many systems have been forced to cancel routine operations and postpone in person appointments and diagnostic tests.

In the United Kingdom, which has the highest vaccination rate amongst large countries, the British Medical Association (BMA) estimates in the UK between April 2020 and March 2021 there were:

June 16, 2021

The chairman of the eagerly-awaited 31st MedTech Investing Europe Forum says the healthcare sector is “back at the top” in global venture capital priorities with the Covid-19 pandemic demonstrating the importance of healthcare and life sciences.

The chairman of the eagerly-awaited 31st MedTech Investing Europe Forum says the healthcare sector is “back at the top” in global venture capital priorities with the Covid-19 pandemic demonstrating the importance of healthcare and life sciences.

September 18, 2020

Early bird families, private wealth holders, healthcare corporations and venture capitalists will access cutting-edge life science innovations at Campden Wealth’s milestone 30th MedTech Investing Europe Conference, only a month away on 21-22 October, 2020.

Early bird families, private wealth holders, healthcare corporations and venture capitalists will access cutting-edge life science innovations at Campden Wealth’s milestone 30th MedTech Investing Europe Conference, only a month away on 21-22 October, 2020.

June 1, 2020

LXRepair will present to global investors its new approach to personalised cancer therapies at the Campden Wealth MedTech Investing Europe Conference in September 2020.

LXRepair will present to global investors its new approach to personalised cancer therapies at the Campden Wealth MedTech Investing Europe Conference in September 2020.

The French medtech company is pioneering the development of functional comprehensive DNA repair and DDR assay and has researched the science behind DNA repair mechanisms and in vitro diagnostics for cancer over the past 25 years.

April 28, 2020

The coronavirus pandemic has triggered a race for disruptive innovation in diagnostics, new therapies and novel vaccines, but the global life sciences industry was already expected to reach more than $2 trillion in gross value by 2023, up from $1.6 trillion before the crisis.

The coronavirus pandemic has triggered a race for disruptive innovation in diagnostics, new therapies and novel vaccines, but the global life sciences industry was already expected to reach more than $2 trillion in gross value by 2023, up from $1.6 trillion before the crisis.

Click here >>
Close